An overview of insulin pumps and glucose sensors for the generalist

Journal of Clinical Medicine

Volumn 5, Issue 1, 2016, Pages

  McAdams, Brooke H ^a   Rizvi, Ali A ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Glucose sensor; Insulin pump; Monitoring; Pancreas

Indexed keywords

BLOOD GLUCOSE MONITORING; CLINICAL DECISION MAKING; COMPUTER PROGRAM; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; GENERAL PRACTITIONER; GLUCOSE SENSOR; HEALTH CARE COST; HEALTH STATUS; HUMAN; HYPOGLYCEMIA; INSULIN INFUSION; INSULIN PUMP; INSULIN RESISTANCE; KNOWLEDGE; MEDICAL CARE; MEDICAL DEVICE REGULATION; MEDICAL TECHNOLOGY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERIOPERATIVE PERIOD; PREGNANCY; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT;

EID: 85091032418     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm5010005     Document Type: Review

References (40)

1. Whiting, D.R.; Guariguata, L.; Weil, C.; Shaw, J. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 1999, 94, 311-321. [CrossRef] [PubMed]
2. Radermecker, R.P.; Scheen, A.J. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: Efficacy, safety, quality of life, and cost-effectiveness. Diabetes Metab. Res. Rev. 2004, 20,178-188. [CrossRef] [PubMed]
3. Riley, W.J.; Silverstein, J.H.; Rosenbloom, A.L.; Spillar, R.; McCallum, M.H. Ambulatory diabetes management with pulsed subcutaneous insulin using a portable pump. Clin. Pediatrics (Phila) 1980,19, 609-614. [CrossRef]
4. Diabetes Self Management. Insulin Pumps (updated June 20, 2014). Available online http://www.diabetesselfmanagement.com/diabetes-resources/tools-tech/insulin-pumps/ (accessed on 3 November 2015).
5. David, G.; Gill, M.; Gunnarsson, C.; Shafiroff, J.; Edelman, S. Switching from multiple daily injections to CSII pump therapy: Insulin expenditures in type 2 diabetes. Am. J. Manag. Care 2014, 20, e490-e497. [PubMed]
6. Mecklenburg, R.S.; Benson, E.A.; Benson, J.W.J. Long-term metabolic control with insulin pump therapy. Report of experience with 127 patients. N. Engl. J. Med. 1985, 212, 465-468. [CrossRef] [PubMed]
7. Davidson, P.C.; Hebblewhite, H.R.; Steed, R.D.; Bode, B.W. Analysis of guidelines for basal-bolus insulin dosing: Basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr. Pract. 2008,14,1095-1101. [CrossRef] [PubMed]
8. Hanaire-Broutin, H.; Melki, V.; Bessières-Lacombe, S.; Tauber, J.P. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: A randomized study. The Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care 2000, 23,1232-1235. [CrossRef] [PubMed]
9. DeVries, J.H.; Snoek, F.H.; Kostense, P.J.; Masurel, N.; Heine, R.J. Dutch Insulin Pump Study Group. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 2002, 25, 2074-2080. [CrossRef] [PubMed]
10. Pickup, J.; Mattock, M. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomised controlled trials. BMJ 2002, 324(7339), 705. [CrossRef] [PubMed]
11. Sulli, N.; Shashaj, B. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: Decreased HbA1c with low risk of hypoglycemia. J. Pediatr. Endocrinol. Metab. 2003,16, 393-399. [CrossRef] [PubMed]
12. Cummins, E.; Royle, P.; Snaith, A.; Greene, A.; Robertson, L.; McIntyre, L.; Waugh, N. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: Systematic review and economic evaluation. Health Technol. Assess. 2010, 14, 1-181. [CrossRef] [PubMed]
13. Hoogma, R.P.; Hammond, P.J.; Gomis, R.; Kerr, D.; Bruttomesso, D.; Bouter, K.P.; Wiefels, K.J.; de la Calle, H.; Schweitzer, D.H.; Pfohl, M.; et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: Results of the 5-nations trial. 5-Nations Study Group. Diabet Med. 2006,23,141-147. [CrossRef] [PubMed]
14. Floyd, J.C.J.; Cornell, R.G.; Jacober, S.J. A prospective study identifying risk factors for discontinuance of insulin pump therapy. Diabetes Care 1993,16,1470-1478. [CrossRef] [PubMed]
15. Ponder, S.W.; Skyler, J.S.; Kruger, D.F.; Matheson, D.; Brown, B.W. Unexplained hyperglycemia in continuous subcutaneous insulin infusion: Evaluation and treatment. Diabetes Educ. 2008, 34, 327-333. [CrossRef] [PubMed]
16. Scheiner, G.; Sobel, R.J.; Smith, D.E.; Pick, A.J.; Kruger, D.; King, J.; Green, K. Insulin pump therapy: Guidelines for successful outcomes. Diabetes Educ. 2009, 35 (Suppl. 2), 29S-41S. [CrossRef] [PubMed]
17. Liberman, A.; Buckingham, B.; Phillip, M. Diabetes technology and the human factor. Int. J. Clin. Pract. Suppl. 2011, 65, 83-90. [CrossRef] [PubMed]
18. Schmidt, S.; N0rgaard, K. Sensor-augmented pump therapy at 36 months. Diabetes Technol. Ther. 2012, 14, 1174-1177. [CrossRef] [PubMed]
19. Maran, A.; Crepaldi, C.; Tiengo, A.; Grassi, G.; Vitali, E.; Pagano, G.; Bistoni, S.; Calabrese, G.; Santeusanio, F.; Leonetti, F.; et al. Continuous subcutaneous glucose monitoring in diabetic patients: A multicenter analysis. Diabetes Care 2002, 25, 347-352. [CrossRef] [PubMed]
20. Tanenberg, R.; Bode, B.; Lane, W.; Levetan, C.; Mestman, J.; Harmel, A.P.; Tobian, J.; Gross, T.; Mastrototaro, J. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: A randomized controlled trial. Mayo Clin. Proc. 2004, 79, 1521-1526. [CrossRef] [PubMed]
21. Blevins, T.C. Professional continuous glucose monitoring in clinical practice. J. Diabetes Sci. Technol. 2010, 4, 440-456. [CrossRef] [PubMed]
22. Halvorson, M.; Carpenter, S.; Kaiserman, K.; Kaufman, F.R. A pilot trial in pediatrics with the sensor-augmented pump: Combining real-time continuous glucose monitoring with the insulin pump. J. Pediatr. 2007,150,103-105. [CrossRef] [PubMed]
23. Bergenstal, R.M.; Tamborlane, W.V.; Ahmann, A. STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N. Engl. J. Med. 2010, 363, 311-320. [CrossRef] [PubMed]
24. Buse, J.B.; Kudva, Y.C.; Battelino, T.; Davis, S.N.; Shin, J.; Welsh, J.B. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technol. Ther. 2012, 14, 644-647. [CrossRef] [PubMed]
25. Bailey, T.; Bode, B.W.; Christiansen, M.P.; Klaff, L.J.; Alva, S. The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technol. Ther. 2015,17, 787-794. [CrossRef] [PubMed]
26. Bergenstal, R.M.; Klonoff, D.C.; Garg, S.K.; Bode, B.W.; Meredith, M.; Slover, R.H.; Ahmann, A.J.; Welsh, J.B.; Lee, S.W.; Kaufman, F.R.; ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N. Engl. J. Med. 2013, 369, 224-232. [CrossRef] [PubMed]
27. Shah, V.N.; Shoskes, A.; Tawfik, B.; Garg, S.K. Closed-loop system in the management of diabetes: Past, present, and future. Diabetes Technol. Ther. 2014,16, 477-490. [CrossRef] [PubMed]
28. Klonoff, D.C.; Buckingham, B.; Christiansen, J.S.; Montori, V.M.; Tamborlane, W.V.; Vigersky, R.A.; Wolpert, H.; Endocrine Society. Continuous glucose monitoring: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2011, 96, 2968-2979. [CrossRef] [PubMed]
29. Haveman, J.W.; Logtenberg, S.J.; Kleefstra, N.; Groenier, K.H.; Bilo, H.J.; Blomme, A.M. Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump. Langenbecks Arch. Surg. 2010, 395, 65-71. [CrossRef] [PubMed]
30. Renard, E.; Place, J.; Cantwell, J.M.; Chevassus, H.; Palerm, C.C. Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: Feasibility study testing a new model for the artificial pancreas. Diabetes Care 2010, 33,121-127. [CrossRef] [PubMed]
31. Russell, S.J.; El-Khatib, F.H.; Sinha, M.; Magyar, K.L.; McKeon, K.; Goergen, L.G.; Balliro, C.; Hillard, M.A.; Nathan, D.M.; Damiano, E.R. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N. Engl. J. Med. 2014, 371, 313-325. [CrossRef] [PubMed]
32. Tauschmann, M.; Hovorka, R. Insulin pump therapy in youth with type 1 diabetes: Toward closed-loop systems. Expert Opin. Drug Deliv. 2014,11, 943-955. [CrossRef] [PubMed]
33. Cryer, P.E. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N. Engl. J. Med. 2004, 350, 2272-2279. [CrossRef] [PubMed]
34. Reznik, Y.; Cohen, O. Insulin pump for type 2 diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes. Diabetes Care 2013, 36 (Suppl. 2), S219-S225. [CrossRef] [PubMed]
35. Kallas-Koeman, M.M.; Kong, J.M.; Klinke, J.A.; Butalia, S.; Lodha, A.K.; Lim, K.I.; Duan, Q.M.; Donovan, L.E. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes. Diabetologia 2014, 57, 681-689. [CrossRef] [PubMed]
36. Blumer, I.; Hadar, E.; Hadden, D.R.; Jovanovic, L.; Mestman, J.H.; Murad, M.H.; Yogev, Y. Diabetes and pregnancy: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2013, 98, 4227-4249. [CrossRef] [PubMed]
37. Lansang, M.C.; Modic, M.B.; Sauvey, R.; Lock, P.; Ross, D.; Combs, P.; Kennedy, L. Approach to the adult hospitalized patient on an insulin pump. J. Hosp. Med. 2013, 8, 721-727. [CrossRef] [PubMed]
38. Peyrot, M.; Rubin, R.R.; Chen, X.; Frias, J.P. Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus. Diabetes Technol. Ther. 2011, 13, 471-476. [CrossRef] [PubMed]
39. Conget, I.; Castaneda, J.; Petrovski, G.; Guerci, B.; Racault, A.-S.; Reznik, Y.; Cohen, O.; Runzis, S.; de Portu, S.; Aronson, R.; et al. The impact of insulin pump therapy on glycemic profiles in patients with type 2 diabetes: Data from the OpT2mise Study. Diabetes Technol. Ther. 2015. [CrossRef]
40. Bulchandani, D.G.; Konrady, T.; Hamburg, M.S. Clinical efficacy and patient satisfaction with U-500 insulin pump therapy in patients with type 2 diabetes. Endocr. Pract. 2007, 13, 721-725. [CrossRef] [PubMed]